SCHEMBL6805798

SCHEMBL6805798

Cc1cc(S(=O)(=O)c2ccc(CC(C)NC(=O)C(F)(F)F)cc2)cc(C(=O)O)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.39
KCNH2 Q12809 1/20 0.39
GAA P10253 1/20 0.38
PHLPP2 Q6ZVD8 1/20 0.38
HMGB1 P09429 1/20 0.37
CXCL12 P48061 1/20 0.37
CNR1 P21554 2/20 0.36
ACACB O00763 2/20 0.36
CDK2 P24941 1/20 0.35
BCL2L1 Q07817 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
POLB P06746 1/20 0.34
ABCC9 O60706 1/20 0.33
ABCC8 Q09428 1/20 0.33
KCNJ11 Q14654 1/20 0.33
KCNJ8 Q15842 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805802 1.00 ESR1 (0.39) ESR1KCNH2GAAPHLPP2HMGB1
SCHEMBL6800681 0.86 ALDH1A1 (0.42) ESR1KCNH2GAACNR1ACACB
SCHEMBL6677754 0.86 ALDH1A1 (0.42) ESR1KCNH2GAACNR1ACACB
SCHEMBL6540853 0.84 ESR1 (0.42) ESR1KCNH2GAACNR1ACACB
SCHEMBL6680778 0.84 CNR1 (0.40) ESR1KCNH2GAACNR1ACACB
SCHEMBL6677082 0.81 ACACB (0.50) ESR1KCNH2GAAACACBNPC1
SCHEMBL6539913 0.81 ESR1 (0.46) ESR1KCNH2GAACNR1ACACB
SCHEMBL6541437 0.81 ESR1 (0.46) ESR1KCNH2GAACNR1ACACB
SCHEMBL6541239 0.79 CNR1 (0.44) ESR1KCNH2CNR1ACACBTSHR
SCHEMBL6541264 0.79 ACACB (0.41) ESR1KCNH2GAACNR1ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 ESR1 3850/4885KCNH2 184/4885GAA 3654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.